TrialInvestigational new drugs2007
Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma.
Matthew D Galsky et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
49 papers cite it
this paperpooled ittrialcites it